Related Experiment Video
Updated: Aug 23, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Midterm Outcomes After Surgical Management for Mitral Valve Regurgitation in Infancy
Toshi Maeda1, Keiichi Fujiwara1, Kosuke Yoshizawa1
1Department of Cardiovascular Surgery, 13863Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
Insights
Mitral valve repair in infants with mitral regurgitation is safe and effective, showing good midterm results. This pediatric heart surgery offers a viable option for complex cases, improving patient outcomes.
Area of Science:
- Pediatric Cardiology
- Cardiac Surgery
- Congenital Heart Disease
Background:
- Mitral valve repair is the preferred treatment for pediatric mitral valve disease.
- Infant mitral valve repair presents significant technical challenges due to complex lesions, limited surgical access, and tissue fragility.
Purpose of the Study:
- To evaluate the midterm outcomes of mitral valve surgery for mitral regurgitation in infants.
- To assess the safety and feasibility of mitral valve repair in this challenging patient population.
Main Methods:
- Retrospective review of 18 infants (<12 months old) undergoing mitral valve surgery for mitral regurgitation.
- Analysis of diverse etiologies including torn chordae, leaflet prolapse, hypoplasia, cleft, endocarditis, papillary muscle rupture, and hammock valve.
- Follow-up data collected to assess reoperation rates, residual regurgitation, and survival.
Main Results:
- No operative mortality; one late death.
- Median follow-up of 7 years, 9 months.
- 15 patients had mild or no mitral regurgitation post-repair; survival and reoperation-free rates at 10 years were 83.0%.
Conclusions:
- Mitral valve repair for mitral regurgitation in infancy is a safe and feasible procedure.
- Satisfactory midterm outcomes can be achieved, even in infants with severe preoperative conditions.
- This approach offers a promising surgical option for pediatric mitral valve disease.
Background:
Mitral valve repair is preferred for pediatric mitral valve disease. However, it is technically difficult because of complex lesions, poor surgical exposure, and tissue fragility, especially in infants. We investigated the midterm outcomes of mitral valve surgery for mitral regurgitation in infancy.
Methods:
We retrospectively reviewed 18 patients (aged <12 months old) undergoing mitral valve surgery for mitral regurgitation at our institution between October 2005 and March 2019. The patients had 10 acquired and 8 congenital valve lesions as follows: torn chordae (n = 6), leaflet prolapse (n = 4), posterior leaflet hypoplasia (n = 3), anterior leaflet cleft (n = 2), infective endocarditis (n = 1), papillary muscle rupture (n = 1), and hammock valve (n = 1).
Results:
All patients initially underwent mitral valve repair. There was no operative mortality, and 1 case of late death. The median follow-up period was 7 years and 9 months. Reoperation was performed in 3 patients, re-repair (twice) in 1 patient with a hammock valve, and mitral valve replacement in 2 patients. Fifteen patients had at most mild mitral regurgitation at the last follow-up. A transmitral mean pressure gradient of over 5 mm Hg was observed in 3 cases, including the patient with a hammock valve. Postoperative mitral annular diameter increased within the normal range in all patients. Survival and reoperation-free rates at 5 and 10 years were 94.4% and 83.0%, respectively.
Conclusions:
Mitral valve repair for mitral regurgitation in infancy is safe and feasible with satisfactory midterm outcomes, even under serious preoperative conditions.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management

